walidgellad.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

this study made me think of @walidgellad.bsky.social www.cidrap.umn.edu/covid-19/dat...

submitted 10 days ago • 1 comment

Remember E. coli outbreak linked to onions in McDonald's Quarter Pounders? FDA inspectors found dozens of violations at supplier, like: - ignoring biofilm/debris buildup - not using handwashing sinks - cleaning chemicals getting on food www.cbsnews.com/news/fda-rep...

submitted 52 days ago • 1 comment

Truly, one of the best changes to Medicare in decades. If you need a very expensive medicine (or a lot of medicine) and you are on Medicare you now have a hard cap on spending starting on 1/1. That is awesome.

submitted 65 days ago • 1 comment

FDA transfers regulatory oversight of medical maggots and leaches from its device center (the organisms previously regulated as medical devices) to biologics center public-inspection.federalregister.gov/2024-31266.p... More on their clinical applications here pmc.ncbi.nlm.nih.gov/articles/PMC...

submitted 66 days ago • 5 comments

Some news ... I'm thrilled to announce that I'll be joining the Brown School of Public Health as a Professor of Health Services Policy & Practice this upcoming summer, 2025! I'm excited for the move and the opportunity to grow my research in new directions. hspp.sph.brown.edu

submitted 74 days ago • 20 comments

I'm looking for a third paper for a Medicaid managed care-focused panel for ASHE. DM me if interested! Please RT, I'm new to the blue skies...

submitted 77 days ago • 3 comments

Terrible news. STAT publishes the kind of reporting we need more of.

submitted 84 days ago • 0 comments

CP3 Associate Director Dr. Katie Suda is learning from past #drugshortages to help mitigate future ones. take a look at her most recent paper comparing US vs Canada. jamanetwork.com/journals/jam...

submitted 91 days ago • 0 comments

When prescription drug costs are subjectively set by conflicted intermediates who profit off higher prices and misaligned incentives, the sticker shock isn’t really a shock at all. www.wsj.com/health/healt... @wsj.com

submitted 97 days ago • 15 comments

I go on Bluesky to see the critical takes on the new NIH director pick and then go on X to see the supportive ones. Such as it is likely to be. I have an opinion on this but figuring out which site to make a statement.

submitted 97 days ago • 1 comment

🆕from @LilyBessette & CP3's @TimAndersonMD - a third of patients eligible for weight loss 💊would have been excluded from their clinical trials. Read more @JAMAInternalMed jamanetwork.com/journals/jam...

submitted 97 days ago • 0 comments

Reprising this from my AEI colleague Ben Ippolito on the cost of Medicare coverage for GLP-1s. CMS appears to see writing on wall here: As additional indications are approved, most Medicare recipients will get coverage for other co-morbidities. Also, Semaglutide subject to IRA price controls in 2027

submitted 97 days ago • 1 comment

New: Officials will issue proposed rules today to cover weight-loss drugs like Ozempic for millions of patients on Medicare and Medicaid. But. It’s up to Trump’s admin whether to finalize the rules. And RFK Jr. is no fan of Ozempic. www.washingtonpost.com/health/2024/...

submitted 97 days ago • 9 comments

Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs If confirmed as FDA commissioner, Makary would take the lead of the agency as it grapples with high-stakes policy issues that could impact Sesame’s business www.statnews.com/2024/11/24/m...

submitted 99 days ago • 1 comment

My article in @statnews.bsky.social on GLP-1 compounding: the @fda.gov needs to maintain the integrity of its authorities — and the implementation of the Drug Quality and Security Act (DQSA). www.statnews.com/2024/11/19/f...

submitted 101 days ago • 2 comments

I do hope it sticks this time @katiepalmer.bsky.social! Nice comments from @walidgellad.bsky.social and @scottgottliebmd.bsky.social.

submitted 102 days ago • 1 comment

ICYMI: Our team previously showed ⬆️prices for indomethacin suppositories. Now, we found wide variation in hospital charges for this drug - charges passed to patients b/c the suppositories are excluded from Medicare Parts B&D. More in JAMA Network Open jamanetwork.com/journals/jam...

submitted 104 days ago • 0 comments

The Trump transition is closing in on a number of names for top health posts across HHS. w/ @adamcancryn.bsky.social www.politico.com/news/2024/11...

submitted 104 days ago • 3 comments

Our partners at VA Pittsburgh are conducting a national search for a new CHERP Co-Director. CHERP is a research powerhouse with major impact on the health of #Veterans. Investigators collaborate closely with each other and Pitt faculty. More info/apply: www.cherp.research.va.gov/jobs/Directo...

submitted 110 days ago • 0 comments

Where was this Peter Marks when no one would say anything except ‘safe and effective’ during COVID? Marks: “Nobody has said that vaccines are perfectly safe. Vaccines have a benefit-to-risk [ratio] that’s highly favorable”

submitted 107 days ago • 0 comments

Cross posting to make sure this is seen. Travel awards available for grad students for our pharmacoequity conference. #healthpolicy www.cp3.pitt.edu/pharmacoequi...

submitted 339 days ago • 0 comments

We don't want to brag (okay, yes we do), but 👀 this policy panel for our #Pharmacoequity2024 conference! We have @seethal_jacobmd, @reshmagar, & @DrKMSimon. Don't miss their talks! Register to join virtually or in-person @PittTweet! calendar.pitt.edu/event/3rd_an...

submitted 356 days ago • 0 comments

Allow us to introduce the incredible research panelists at our #Pharmacoequity2024 Conference: @landgrantdan, @IshaniG, & @DrJuanHC! Register today to catch their talks - and the talks of our other 🌟speakers: calendar.pitt.edu/event/3rd_an... Free, hybrid, open to all!

submitted 355 days ago • 0 comments

CMS has updated its announcement that it is closing down physical access to data. Here are some key tracked changes. Seems like some openness to adjusting the timelines for the transition - though not whether it's happening. (Announcement here: www.cms.gov/data-researc... )

submitted 367 days ago • 1 comment

Oral naltrexone is one of main medications doctors can turn to for treating alcohol use disorder FDA now lists it in shortage, with multiple manufacturers citing a "Shortage of an active ingredient" or "Demand increase for the drug" www.accessdata.fda.gov/scripts/drug...

submitted 367 days ago • 0 comments

I’m not posting much here, but I’d like to point out that it is tweets like this that exaggerate study findings. Stat shouldn’t do this. This study design cannot measure impact of COVID on cognition. Rather it compares cognition in those with and without COVID/symptoms with no baseline measure.

submitted 366 days ago • 0 comments

This is absolutely a major problem.

submitted 383 days ago • 0 comments

Save the date! Our 3rd Annual Pharmacoequity Conference is May 3, 2024. Dr. Fumiko Chino will join us as Keynote, & we'll have a group of other amazing speakers who are advancing health equity. Join in person on the Pitt campus or on Zoom wherever you are! Watch for more info in January!

submitted 458 days ago • 0 comments

This will undoubtedly be accompanied by major limits by insurers on who gets the drug….Unless Pfizer has some more positive data somewhere, including on long covid.

submitted 504 days ago • 0 comments

Prospective PhD students: Applications are now open for the #PittHPM Health Services Research and Policy PhD program! Join #PittPubHealth for info sessions in October (virtual) and November 3 (in-person)

submitted 511 days ago • 1 comment

The Department of Health Policy and Management at Pitt is hiring tenure track faculty in policy and health services research. Apply. French fries on salads. https://cfopitt.taleo.net/careersection/pitt_faculty_external/jobdetail.ftl?job=22000867&tz=GMT-04%3A00&tzname=America%2FNew_York

submitted 524 days ago • 0 comments

Re-upping this since the health policy contingent is slowly but steadily growing: BlueSky has "feeds," which are sort of like Twitter's lists, but you typically need to use a keyword (or key emoji) to have a post feature in the feed. I created a health policy feed here:

submitted 565 days ago • 2 comments

Where do I announce a faculty recruitment to Pitt that I am really excited about? Here or on the other place?

submitted 585 days ago • 1 comment

Robert Califf's battling misinformation -- but with questionable facts and framings of his own. My latest: https://kffhealthnews.org/news/article/fda-head-robert-califf-battles-misinformation-sometimes-with-fuzzy-facts/

submitted 588 days ago • 0 comments

Welcome, @bnrome.bsky.social ! Check out the health policy list and instructions for contributing to that feed. You can pin the feed to easily get back to it.

submitted 596 days ago • 0 comments

Original Humira’s list price grew so much that its actual price after rebates to Medicaid was zero. (It will be fascinating to see what happens in Medicare with inflation rebate). #healthpolicy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2807194

submitted 597 days ago • 0 comments

ICER's report on sickle cell disease🧪 is out today! Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M #healthpolicy

submitted 599 days ago • 0 comments

“Another hospital attempted to charge a patient a facility fee of up to $350 for a telehealth visit because the doctor was on hospital property.” 🙃 #healthpolicy https://www.statnews.com/2023/07/07/hospital-facility-fees-biden-initiative/

submitted 602 days ago • 0 comments

Happy to share our new piece answering the ? "What bar should CMS consider when determining what 'bona fide generic entry' means." #healthpolicy https://www.nejm.org/doi/full/10.1056/NEJMp2304289?query=WB&cid=NEJM%20Weekend%20Briefing,%20July%208,%202023%20DM2259601_NEJM_Subscriber&bid=1665394310

submitted 603 days ago • 0 comments

Testing the waters here. this ability to follow specific feeds based on hashtags right from the app is a big plus. Although not to ruin things but I see potential for topic specific ads in specific feeds.

submitted 604 days ago • 0 comments